Related Experiment Video
Updated: Mar 1, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Modelling disease activity in juvenile dermatomyositis: A Bayesian approach
Eh Pieter van Dijkhuizen1,2, Claire T Deakin3, Lucy R Wedderburn3,4
11 Paediatric Rheumatology, IRCCS G. Gaslini, Italy.
This study developed a Bayesian joint model to analyze juvenile dermatomyositis (JDM) disease activity. The model accurately predicts disease progression and identifies key clinical markers for patient stratification and treatment guidance.
Area of Science:
- Rheumatology
- Pediatrics
- Biostatistics
Background:
- Juvenile dermatomyositis (JDM) is the most common idiopathic inflammatory myopathy in children, marked by muscle and skin inflammation.
- JDM presents with symmetric proximal muscle weakness and characteristic skin symptoms, exhibiting a variable clinical course and prognosis.
Purpose of the Study:
- To develop a robust statistical model for analyzing longitudinal outcomes in JDM.
- To account for within- and inter-individual variability in disease activity.
- To identify clinical markers associated with disease progression and prognosis.
Main Methods:
- A Bayesian joint model was implemented to analyze four longitudinal outcomes in JDM.
- The model incorporated subject-specific random effects to capture correlations among outcomes.
- A hurdle model approach was used to handle excess outcomes, with clinical markers as covariates.
Main Results:
- The developed model demonstrated good performance, providing efficient parameter estimations and accurate predictions of disease activity.
- A significant correlation was found between two outcome variables, indicated by the posterior distribution of random intercepts.
- Several clinical markers and symptoms were identified as significantly associated with JDM disease activity.
Conclusions:
- The statistical model effectively captures the complex dynamics of JDM.
- Identified clinical markers can aid in stratifying JDM patients based on prognosis.
- Findings support improved clinical decision-making and guide future research on JDM outcome markers.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Model Approaches for Pharmacokinetic Data: Physiological Models

